Cancer Types, Treatment and Research
AACR CEO Margaret Foti Receives Honorary M.D. from The University of San Pablo CEU
Madrid, Spain (Vocus) June 17, 2009 -- The University of San Pablo CEU, a major academic and research institution in Madrid, Spain, today presented Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the American Association for Cancer Research, with an honorary doctorate in medicine that recognizes her exceptional contributions to cancer research and leadership of the AACR, which have done so much to help those suffering from cancer.
“Margaret Foti exemplifies the social leadership and management needed worldwide for the prevention and treatment of cancer. Her tireless efforts on behalf of patients and scientists are now visible through the impressive resources that AACR is providing today to the international scientific community. Her years devoted to cancer research development and communication have inspired several generations of scientists to move forward to even greater heights, and we are proud to honor her with this degree,” Fernando Vidal-Vanaclocha, M.D., professor at Basque Country University and pioneer of cancer metastasis research in Spain, said at today’s ceremony.
Vidal-Vanaclocha presented Foti with the degree of M.D. “honoris causa.” The degree is the first of its kind given in the University’s 75-year history.
“Such awards in themselves have a special significance, but I personally believe that this is an honor that does justice to your exceptional work in the field of cancer research and to your leadership of an international organization that has done so much to advance our knowledge about cancer diseases and, therefore, to help those suffering from cancer,” said Vidal-Vanaclocha.
Foti had been notified of the degree by the Governing Council of the University chaired by Alfredo Dagnino and was sworn in as M.D. “honoris causa” by the University Rector Alfonso Bullon de Mendoza.
“I am deeply humbled by this extraordinary recognition of my work, and I want to thank the university for seeing fit to honor me,” said Foti. “This honorary degree is recognition of the hard work of all our members around the world, as well as our AACR staff, all of whom are working hard every day to solve the problem of cancer, which is truly worldwide.”
Foti said the global burden of cancer continues to increase by about one percent per year, with even greater increases in China, India and Russia.
“Cancer is expected to surpass cardiovascular disease as the number one cause of death worldwide in 2010, and global incidence of cancer has more than doubled in three decades,” said Foti. “This rapid increase represents a crisis in public health, and there is an increasing sense of urgency worldwide for us to find solutions to the cancer problem.”
The University of San Pablo CEU was founded to develop future leaders of Spanish society, and its alumni include ministers, heads of major national and international companies, writers, artists, academics and scientists. The university currently serves just over 7,000 students and has 890 faculty members.
Foti has been CEO of the American Association for Cancer Research since 1982. During her tenure, the membership has grown from 3,000 to more than 28,000 scientists residing in nearly 90 countries. She began her career as an editorial assistant for Cancer Research, the most highly cited cancer journal in the world and was rapidly promoted to managing editor. Under Foti’s leadership as CEO, the AACR has launched five additional journals that together contribute approximately 20 percent of all peer reviewed cancer literature.
In addition, the AACR holds 20 meetings a year on timely scientific subjects and five educational workshops that train basic and clinical scientists. The AACR also facilitates programs on survivorship issues, plays a key role in science policy and is the scientific partner of Stand Up To Cancer, a groundbreaking cancer funding initiative.
The honorary degree she received today is Foti’s third. In 2003, she received an Honorary Doctorate in Medicine and Surgery from the University of Rome La Sapienza, and in 2008 she received a second Honorary Doctorate in Medicine and Surgery from the University of Catania in Sicily.
Foti has received many national and international awards for her contributions to cancer research: the Award of Appreciation from the Frontiers in Cancer Prevention Research Chairpersons, the Award with Recognition and Appreciation from the Israel Cancer Association, the Italian League Against Cancer Commendation, the Distinguished Service Award from the George Washington University Medical Center’s GW Cancer Institute, the Distinguished Service Award from the Association of American Cancer Institutes, the AACR Award for Leadership and Extraordinary Achievements in Cancer Research, the Ville de Paris Award, the Cina del Duca Award for raising public awareness of cancer globally, the Community Caring Award from the William S. Graham Foundation for Melanoma Research, and the Special Recognition Award from the American Society of Clinical Oncology.
Most recently, in March of this year, she received the first Margaret Kripke Legend Award from the University of Texas M. D. Anderson Cancer Center. Last month she was cited by Philadelphia Mayor Michael Nutter for her dedication to increasing awareness of the importance of cancer research.
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes more than 28,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and nearly 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.
###
MORE ARTICLES:
Resource Website Directory
A helpful directory of websites and other online resources.
St. Helena Hospital Cancer Center Affiliates with UCSF Medical Center to Enhance Local Cancer Treatment
The patient-centered, Martin-O'Neil Cancer Treatment Center at St. Helena Hospital offers world-class care, state-of-the-art technology and three types of oncology in one convenient location. The affiliation with the UCSF Helen Diller Family Comprehensive Cancer Center at UCSF Medical Center will provide North Bay patients with convenient access to cancer treatment specialists through a convenient Napa Valley location.
Cancer - An Overview
Cancer is second only to cardiovascular disease as the leading cause of death in the Western world
Although Cancer is primarily a disease of the elderly with more than 60% of deaths from cancer occurring in those over the age of 65, cancer can strike even the youngest of children
Breast Cancer in Men: The Warning Signs
Breast cancer is traditionally thought of as an exclusively female-related disease But like breast cancer in women, breast cancer in men is the uncontrolled growth of the cells of the breast tissue
Alternative Lung Cancer Treatment
How Alternative Cancer Treatment can help those living with Lung Cancer
Lung cancer involves abnormal cell growth in the lungs, part of the overall respiratory system While doctors cannot explain why one person may develop lung cancer and someone may not, there are several factors that can lead to the development of lung cancer
Men's Health Month: Recognize Your Individual Risk for Bladder Cancer
June is Men's Health Month. Bladder Cancer is more prevalent in men, especially military veterans, firefighters and cigarette smokers. The Men's Health Network offers information. Several physicians cite facts about the disease and insights on how to improve early detection.
To extend the lifeline of cancer patients - cancer, cancer, medicine - pharmaceutical industry
Current medical community does not fully understand the causes of cancer, we know that the carcinogenic factors are the following:
Diabetes Drug Kills Cancer Stem Cells in Combination Treatment in Mice
• Metformin is more effective than chemotherapy alone
• Study supports cancer stem cells hypothesis
• Laboratory study focused on breast cancer cells
Genetic Risk Factors in Breast Cancer
Breast cancer is the most common cancer and the second leading cause of cancer deaths in women in the United States. In 2008, approximately 184,450 patients were estimated to be diagnosed with invasive breast cancer, and an estimated 40,930 were estimated to die of this disease. Furthermore, over 50,000 female carcinoma in situ breast cases would have been diagnosed. The etiology of breast cancer is poorly understood with multiple genetic and environmental factors involved in the initiation and progression of cancer.
Senators Chuck Hagel and Dianne Feinstein Make Lung Cancer Matter
June 25, 2008 marks a revolutionary day in history for anybody who cares about Lung Cancer, the Number One Cancer Killer in this country. It's almost tantamount to July 4th, Independence Day, for Lung Cancer. For the first time, in the last four decades, Lung Cancer finally has a voice, thanks to Senators Chuck Hagel, Dianne Feinstein and the tireless work over the last five years of Laurie Fenton, Sheila Ross and the Lung Cancer Alliance.
Ovarian Cancer Vaccine Clinical Trial Begins At Cancer Treatment Centers of America
FDA-approved study aimed at harnessing immune system to fight tumors.
Cholesterol and Cancer: Answers and Some New Questions
• Study shows low cholesterol as a symptom of cancer rather than a cause.
• Possible benefit of higher HDL and cancer risk.
• Lower cholesterol may lower risk of high-grade prostate cancer.
New Leader In Cancer Community To Be Announced At Summit
The Wellness Community and Gilda’s Club Unify to Provide Support to All People Affected By Cancer
Cancer Awareness Jewelry: Hope and Charm Bracelets
In recent years, the ongoing battle for a breast cancer cure has gained notoriety as more and more lives have become touched by the devastating emotional and physical trials of cancer Yet where the malignancy of cancer lurks, supportive movements such as the recent popularization of Cancer Awareness Jewelry prevail, helping to sustain the fight against the disease and fortify the battle for a cure
Commonly Asked Questions After Mesothelioma Treatment
There are some questions that will be on the mind of mesothelioma patients after the finish their course of therapyThe common questions are:
1- Can I be assured the cancer will never come back
